Abstract
Purpose
To evaluate safety and efficacy of hypertonic saline solution administration after uneventful cataract surgery.
Design
Prospective double-blind randomized study
Methods
In total, 183 eyes of 183 patients undergoing phacoemulsification were randomly allocated into two equal groups. Treatment group (TG) subjects received single-dose hypertonic (NaCl 5%) solution 4 times daily for 14 days, while placebo group (PG) received single dose of normal saline solution (0.9%) at the same frequency in addition to ordinary postoperative treatment. All patients underwent assessment of central corneal thickness (CCT), endothelial cell density (ECD), best-corrected visual acuity (BCVA), clinical staging of postoperative corneal edema and questionnaire regarding the procedure success and impact on patient’s life. Measurements were taken at baseline and 1, 4, 9 and 30 days following surgery.
Results
CCT increased by 134.67 ± 94.51 μm (25.1 ± 19.4%) on postoperative day 1, without any difference between study groups (p = 0.58). Corneal edema showed a significant recession in TG compared to PG on day 4, in terms of both pachymetry (10.73% vs 7.39%, p = 0.004), BCVA (BCVATG = 0.64 ± 0.24 [logMARTG = 0.25 ± 0.3], BCVAPG = 0.56 ± 0.23 [logMARPG = 0.33 ± 0.3], p = 0.04) and clinical staging (p = 0.02). Similar results were recorded on postoperative day 9 in subjects demonstrating marked corneal edema on the first postoperative day. Endothelial cell loss showed no statistically significant difference between study groups (p = 0.48). No adverse events were recorded in relation to treatment. More patients in the TG (92.4% vs 57.1% in the PG) reported a subjectively clear vision 1 week postoperatively (p = 0.04).
Conclusion
The use of 5% hypertonic saline solution is found to be a safe and effective adjunct in the management of postoperative corneal edema after uneventful phacoemulsification, achieving rapid corneal clearance and expediting a good visual outcome, especially in cases with marked postoperative edema.
Similar content being viewed by others
References
DelMonte DW, Kim T (2011) Anatomy and physiology of the cornea. J Cataract Refract Surg 37:588–598
Rao SK, Ranjan Sen P, Fogla R et al (2000) Corneal endothelial cell density and morphology in normal Indian eyes. Cornea 19:820–823
Levenson JE (1975) Corneal edema: cause and treatment. Surv Ophthalmol 20:190–204
Maharana PK, Sharma N, Vajpayee RB (2013) Acute corneal hydrops in keratoconus. Indian J Ophthalmol 61:461–464
Rosado-Adames N, Afshari NA (2012) The changing fate of the corneal endothelium in cataract surgery. Curr Opin Ophthalmol 23:3–6
Sharma N, Singhal D, Nair SP, Sahay P, Sreeshankar SS, Maharana PK (2017) Corneal edema after phacoemulsification. Indian J Ophthalmol 65:1381–1389
Tsaousis KT, Panagiotou DZ, Kostopoulou E, Vlatsios V, Stampouli D (2015) Corneal oedema after phacoemulsification in the early postoperative period: a qualitative comparative case-control study between diabetics and non-diabetics. Ann Med Surg (Lond) 5:67–71
Van Cleynenbreugel H, Remeijer L, Hillenaar T (2014) Cataract surgery in patients with Fuchs' endothelial corneal dystrophy: when to consider a triple procedure. Ophthalmology 121:445–453
Costagliola C, Romano V, Forbice E, Angi M, Pascotto A, Boccia T, Semeraro F (2013) Corneal oedema and its medical treatment. Clin Exp Optom 96:529–535
Ho W, Yin G, Sampo M, Soare S, Hoffart L (2015) Visual acuity, pachymetry and corneal density after 5% sodium chloride treatment in corneal edema after surgery. J Fr Ophtalmol 38:967–973
Rouland JF (2015) Clinical pilot study to evaluate the efficacy of a preservative-free hypertonic ophthalmic solution for patients with symptomatic corneal edema. J Fr Ophtalmol 38:800–808
Khripun KV, Nizametdinova Y, Varganova TS (2018) Therapeutic efficacy of 3% NaCl hypertonic solution in postoperative corneal edema. Ophthalmol J 11:81–86
Perone JM, Boiche M, Lhuillier L, Ameloot F, Premy S, Jeancolas AL, Goetz C, Neiter E (2018) Correlation between postoperative central corneal thickness and endothelial damage after cataract surgery by phacoemulsification. Cornea 37:587–590
Yin GHW, Levy N (2018) Clinical results after 5% sodium chloride treatment in post-operative corneal oedema. J Eye Dis Disord 3:113
Luxenberg MN, Green K (1971) Reduction of corneal edema with topical hypertonic agents. Am J Ophthalmol 71:847–853
Marisi A, Aquavella JV (1975) Hypertonic saline solution in corneal edema. Ann Ophthalmol 7:229–233
Knezović I, Dekaris I, Gabrić N, Cerovski J, Barisić A, Bosnar D, Rastegorac P, Parać A (2006) Therapeutic efficacy of 5% NaCl hypertonic solution in patients with bullous keratopathy. Coll Antropol 30:405–408
Narayanan R, Gaster RN, Kenney MC (2006) Pseudophakic corneal edema: a review of mechanisms and treatments. Cornea 25:993–1004
Claesson M, Armitage WJ, Stenevi U (2009) Corneal oedema after cataract surgery: predisposing factors and corneal graft. Acta Ophthalmol 87:154–159
Güell JL, El Husseiny MA, Manero F, Gris O, Elies D (2014) Historical review and update of surgical treatment for corneal endothelial diseases. Ophthalmol Ther 3:1–15
Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, Toda M, Hagiya M, Yokota I, Teramukai S, Sotozono C, Hamuro J (2018) Injection of cultured cells with a rock inhibitor for bullous keratopathy. N Engl J Med. 378:995–1003
Okumura N, Koizumi N, Kay EP, Ueno M, Sakamoto Y, Nakamura S, Hamuro J, Kinoshita S (2013) The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci 54:2493–2502
Koizumi N, Okumura N, Ueno M, Nakagawa H, Hamuro J, Kinoshita S (2013) Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy. Cornea 32:1167–1170
Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hirata K, Torii R, Hamuro J, Kinoshita S (2011) Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br J Ophthalmol 95:1006–1009
Funding
No financial grants or funds received in support of the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No proprietary interest in any of the products mentioned in the study. All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study. The study was performed with informed consent and following all the guidelines for experimental investigations required by the Institutional Review Board of Ethics Committee of which all authors are affiliated.
Consent for publication
The contents of this manuscript have not been copyrighted or published previously and will not be submitted elsewhere while consideration for publication. There are no directly related manuscripts or abstracts, published or unpublished, by any authors of this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Asterios Diafas and Argyrios Tzamalis contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tzamalis, A., Dermenoudi, M., Diafas, A. et al. Safety and efficacy of hypertonic saline solution (5%) versus placebo in the treatment of postoperative corneal edema after uneventful phacoemulsification: a randomized double-blind study. Int Ophthalmol 40, 2139–2150 (2020). https://doi.org/10.1007/s10792-020-01395-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01395-4